As a physician, I have spent over a decade observing how the landscape of oncology continues to shift, often in ways that surprise even the most seasoned researchers. In my work as a medical journalist, I frequently encounter reports of “repurposed” medications—drugs that were originally designed for one purpose but are found to hold promise … Read more
Pancreatic cancer remains one of the most challenging malignancies to treat, with limited options and poor survival rates despite advances in oncology. For decades, standard chemotherapy regimens like FOLFIRINOX and gemcitabine-based therapies have formed the backbone of treatment, yet outcomes remain modest, particularly in advanced stages. Recent developments, although, suggest a shift in the therapeutic … Read more
In a medical breakthrough that reads like a scientific miracle, an experimental cellular therapy has successfully “reset” the immune system of a 47-year-old German woman suffering from three simultaneous, life-threatening autoimmune diseases. For more than a decade, the patient lived in a state of critical instability, dependent on daily blood transfusions and continuous medication to … Read more
2026-02-04 15:49:00 La Journée mondiale contre le cancer reste un moment qui souligne à quel point la lutte contre cette maladie demeure une priorité à l’Inserm. Les chercheurs et chercheuses de l’institut sont plus que jamais mobilisés pour faire progresser la recherche sur tous les fronts, qu’il s’agisse de nouvelles thérapies, de stratégies pour mieux … Read more
2026-01-31 15:36:00 Aujourd’hui, selon l’Inserm, près d’un enfant sur trois présente au moins une maladie allergique, et l’asthme reste la pathologie chronique la plus fréquente, touchant entre 7 à 10 % des enfants en France. Eczéma, rhinites allergiques, allergies alimentaires ou crises d’asthme apparaissent de plus en plus tôt, parfois dès les premières années de vie. … Read more